UPDATED May 09, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$412.32 | 3.6% | 33.0% | US$3.1t | US$476.88 | PE35.6x | E12.7% | 0.7% | Software | ||
GOOGL | US$169.96 | 2.0% | 45.8% | US$2.1t | US$191.48 | PE25.5x | E12.2% | 0.5% | Media | ||
AMZN | US$189.50 | 2.6% | 68.9% | US$2.0t | US$217.51 | PE52.3x | E21.5% | n/a | Retail | ||
META | US$475.42 | 7.6% | 101.6% | US$1.2t | US$520.45 | PE26.4x | E12.2% | 0.4% | Media | ||
LLY | US$771.55 | 2.1% | 77.1% | US$697.8b | US$850.41 | PE113.2x | E27.4% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$796.00 | 3.1% | 59.5% | NT$20.6t | NT$915.41 | PE24.1x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,305.67 | 5.4% | 108.0% | US$614.2b | US$1,501.46 | PE52.2x | E23.2% | 1.6% | Semiconductors | ||
NOVO B | kr.883.20 | 1.2% | 52.9% | kr.3.9t | kr.908.65 | PE44.1x | E13.4% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$197.50 | 3.0% | 45.2% | US$561.8b | US$207.83 | PB1.8x | E-1.3% | 2.3% | Banks | ||
WMT | US$60.44 | 1.2% | 18.4% | US$486.0b | US$65.42 | PE31.4x | E10.8% | 1.4% | Consumer Retailing | ||
UNH | US$507.03 | 2.9% | 3.7% | US$463.0b | US$567.36 | PE30.4x | E19.6% | 1.5% | Healthcare | ||
XOM | US$118.44 | 1.9% | 12.0% | US$458.0b | US$131.82 | PE14.2x | E2.5% | 3.2% | Energy | ||
700 | HK$369.80 | 2.6% | 13.3% | HK$3.4t | HK$419.57 | PE27.6x | E15.1% | 0.9% | Media | ||
PG | US$166.04 | 1.3% | 7.5% | US$389.6b | US$170.09 | PE26.4x | E7.2% | 2.4% | Household | ||
A005930 | ₩79,700.00 | 2.2% | 24.1% | ₩529.8t | ₩103,324.32 | PE27.5x | E22.8% | 1.8% | Tech | ||
JNJ | US$149.85 | -0.05% | -6.9% | US$358.5b | US$173.26 | PE21.1x | E6.9% | 3.3% | Pharmaceuticals & Biotech | ||
COST | US$779.04 | 6.4% | 55.2% | US$338.6b | US$777.54 | PE50.9x | E7.5% | 0.6% | Consumer Retailing | ||
HD | US$347.44 | 3.5% | 20.8% | US$335.8b | US$384.23 | PE22.7x | E4.3% | 2.6% | Retail | ||
MRK | US$130.23 | 1.5% | 10.8% | US$328.1b | US$141.64 | PE143x | E24.9% | 2.4% | Pharmaceuticals & Biotech | ||
ORCL | US$116.64 | 1.5% | 19.7% | US$322.6b | US$136.92 | PE30.1x | E14.6% | 1.4% | Software | ||
600519 | CN¥1,756.00 | 3.0% | 2.3% | CN¥2.2t | CN¥2,161.67 | PE28.3x | E12.7% | 2.8% | Food, Beverage & Tobacco | ||
CVX | US$165.45 | 2.9% | 5.9% | US$299.6b | US$183.11 | PE15x | E2.5% | 3.9% | Energy | ||
BAC | US$38.28 | 3.8% | 39.8% | US$294.9b | US$40.08 | PB1.1x | E6.2% | 2.5% | Banks | ||
ABBV | US$160.40 | -0.3% | 9.4% | US$283.3b | US$181.55 | PE47.6x | E23.0% | 3.9% | Pharmaceuticals & Biotech |